Chihiro Yabe
Corporate Officer/Principal chez Kyoto Prefectural University of Medicine
Postes actifs de Chihiro Yabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Kyoto Prefectural University of Medicine | Corporate Officer/Principal | - | - |
Historique de carrière de Chihiro Yabe
Anciens postes connus de Chihiro Yabe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Fondateur | 01/01/2006 | - |
Statistiques
Internationale
| Suisse | 2 |
| 2 |
Opérationnelle
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Bourse
- Insiders
- Chihiro Yabe
- Expérience
